Mika (Kimiaka C.) Guerard PhD MBA
Directrice, Prospective et Intelligence d’affaires @ Axelys
About
About I’m a scientist turned biotech venture builder with 15+ years of experience bridging early-stage drug discovery, venture creation, and translational strategy. I specialize in identifying high-potential therapeutic innovations, building scientific and business plans around them, and guiding programs from academia through preclinical inflection points. Previously with BioMotiv (Cleveland, OH), I was part of a rare model that aligned scientific rigor with venture capital discipline — and I’ve been passionate about this space ever since. I’ve led scientific and executive roles in early-stage startups, helped shape biotech portfolios as an investor, and advised dozens of academic teams on turning discovery into impact. Areas of focus: New company creation Translational planning & target product profile development Fundraising strategy Scientific and operational leadership Early-stage venture investments Scouting & due diligence Open to connecting with founders, VCs, pharma innovation leaders, and translational scientists building the future of medicine.À propos Scientifique de formation, je suis aujourd’hui une bâtisseuse d’entreprises biotechnologiques avec plus de 15 ans d’expérience à l’interface entre la découverte de nouveaux médicaments, la création de startups et l’investissement en capital de risque. Ma spécialité : identifier des innovations thérapeutiques à fort potentiel, concevoir des plans de développement scientifique et stratégique autour de celles-ci, et les amener jusqu’à des jalons précliniques déterminants. Chez BioMotiv (Cleveland, Ohio), j’ai eu la chance de faire partie d’un modèle unique alliant rigueur scientifique et discipline d’investissement — une expérience fondatrice qui a nourri ma passion pour l’innovation translationnelle et la création de valeur à partir de découvertes académiques. J’ai depuis occupé des rôles scientifiques et exécutifs au sein de jeunes biotechs, accompagné des équipes de recherche dans la valorisation de leurs technologies, et contribué à l’évaluation de nombreux projets en phase de démarrage. Domaines d’expertise : Création de startups biotechnologiques Développement translationnel & TPP Stratégie de financement Leadership scientifique et opérationnel Investissement early stage Veille et évaluation de technologies Intéressée à échanger avec des fondateurs, investisseurs, leaders pharmaceutiques et chercheurs œuvrant à transformer les découvertes scientifiques en solutions concrètes pour les patients.
United States
Beachwood
Biotechnology
Drug development, small molecules, immunology, early stage venture, Strategic Planning , Cross-functional Team Leadership , Regulatory Affairs , Intellectual Property Management, Strategic partnership, negotiation, Investor relations, Drug development, small molecules, immunology, early stage venture, Strategic Planning , Cross-functional Team Leadership , Intellectual Property Management, Investor relations, cardiovascular diseases, Drug development, small molecules, immunology, early stage venture, Strategic Planning , Cross-functional Team Leadership , Regulatory Affairs , Intellectual Property Management, Strategic partenships, negotiation, Investor relations, Drug development, small molecules, discovery, oncology, academic partnerships, early stage venture, Strategic Planning , Cross-functional Team Leadership , Regulatory Affairs , Intellectual Property Management , Drug development, venture creation, small molecules, bologics, vaccines, discovery , Research and development , Experimental design , Leadership , Fund raising , Vision , Roadmap , Strategic Planning , Cross-functional Team Leadership , Regulatory Affairs , Intellectual Property Management , Corporate Governance , Industry collaboration , Investor Relations, Drug development, small molecules, discovery , oncology, academic partnerships, early stage venture, Research and development , Experimental design, Vision , Roadmap , Strategic Planning , Cross-functional Team Leadership , Regulatory Affairs , Intellectual Property Management , Industry collaboration , Investor Relations, Investor relation, team management, market analysis, market trends, financial analysis, portfolio management, syndication, business development, Fixed income, presentation, fast paced environment, risk management , Cultural Adaptation, Trading, Total synthesis, Hypervalent iodine, aromatic umpolung, Scientific Papers, Scientific Presentation, Simplifying concepts, team managment, Drug design, Drug development, Pharmaceutical partnership, project management, medicinal chemistry, ADME, PK, discovery, Rare diseases, pulmonary diseases, oncology , Small molecule, rare diseases, Biologics, PROTACS, Drug developement, venture creation, small molecules, bologics, vaccines, discovery , Research and development , Experimental design , Leadership , Fund raising , Vision , Roadmap , Strategic Planning , Cross-functional Team Leadership , Regulatory Affairs , Intellectual Property Management , Corporate Governance , Industry collaboration , Investor Relations
Experience
Directrice, Prospective et Intelligence d’affaires
Axelys
Montreal, Quebec, Canada
Axelys is the partner of choice to transform discoveries within public research institutions into innovation (commerialization)
Scientific Advisor
Neolys Pharma
Neolys Pharma is developing therapies (small molecules) in oncology
Co-Fondatrice - Club CEO
Scientific Advisor
ProxAI
Canada
Vice President - Life Sciences
RBCx
Montreal
RBCx provides financial support to Life Sciences companies. It is the only Canadian bank with a Venture Debt policy dedicated to pre-revenue Life Science companies
Operating partner - investment director
BioMotiv
Cleveland, Ohio
BioMotiv was a Venture studio type investment fund and accelerator developing breakthrough discoveries into therapies. It was acquired by Advent UK in 2023.
Koutif Therapeutics LLC - Director, Drug development
BioMotiv
United States
Koutif was developing "immunotherapies in a pill" and PROTACS for IBD
Sujana Biotech, LLC - Director drug development
BioMotiv
Sujana biotech was developing biologics in Cardiovascular indications
OPTIKIRA, LLC - Director Drug development
BioMotiv
Cleveland, Ohio, United States
OptiKira was developing therapies (small molecules) to treat rare diseases in ophthalmology, oncology as well as metabolic diseases and idiopathic pulmonary fibrosis.
Anteros Bio -Director, Drug development
BioMotiv
United States
Anteros biotech was developing small molecules in rare diseases and pulmonary fibrosis
Associate
Theodorus Investment Funds
Theodorus is an America and European fund focusing in early stage companies in Life Sciences
Research scientist - Drug developement
ZCS
Montreal, Quebec, Canada
Research Assistant- Organic Chemistry
UQAM | Université du Québec à Montréal
Montreal
Syndication and Trader primary markets (Technology, Food science, Italian SMEs)
Credem Banca
Milan, Lombardy, Italy
Position held at Abaxbank, the merchant bank division of Credem (Credito Emiliano). AbaxBank has since ceased its activities.
Education
UQAM | Université du Québec à Montréal
Biochemistry
École des sciences de la gestion (ESG UQAM)
Science and Engineering
UQAM | Université du Québec à Montréal
Organic Chemistry
Mika (Kimiaka C.) Guerard PhD MBA's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.